Syngenta Group has confidentially filed for a Hong Kong initial public offering (IPO), targeting at least $5 billion and potentially as much as $10 billion. The Swiss-based agricultural chemicals and seeds company, a subsidiary of Chinese state-owned enterprise Sinochem Holdings, aims to launch the offering between late this year and early 2027, subject to regulatory approval and market conditions. A $10 billion deal would be Hong Kong’s largest IPO since 2010, according to LSEG data. Syngenta initially planned to file in June but postponed the process because of Middle East geopolitical tensions. The company said it "does not comment on market speculation," while Sinochem did not respond to requests for comment. Syngenta generated $12.2 billion in first-half 2026 revenue, down 2% year-on-year, while EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 2% to $2.4 billion. Its potential listing comes as SHEIN advances its own Hong Kong plans and could support renewed activity in the city’s IPO market. The final fundraising size and timing remain under negotiation and will depend on investor response, interest rates, geopolitical conditions, and regulatory approval.